Ashfield Capital Partners’s Procter & Gamble PG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $11.2M | Sell |
88,815
-1,691
| -2% | -$240K | 0.94% | 28 |
|
|
2022
Q2 | $13M | Sell |
90,506
-190
| -0.2% | -$28.6K | 1.01% | 30 |
|
|
2022
Q1 | $13.9M | Sell |
90,696
-840
| -0.9% | -$131K | 0.9% | 29 |
|
|
2021
Q4 | $15M | Sell |
91,536
-4,697
| -5% | -$697K | 0.96% | 27 |
|
|
2021
Q3 | $13.5M | Sell |
96,233
-549
| -0.6% | -$77.8K | 0.96% | 26 |
|
|
2021
Q2 | $13.1M | Buy |
96,782
+113
| +0.1% | +$15.3K | 0.93% | 29 |
|
|
2021
Q1 | $13.1M | Sell |
96,669
-2,371
| -2% | -$309K | 1.04% | 27 |
|
|
2020
Q4 | $13.8M | Sell |
99,040
-119
| -0.1% | -$16.6K | 1.12% | 24 |
|
|
2020
Q3 | $13.8M | Sell |
99,159
-1,643
| -2% | -$218K | 1.25% | 23 |
|
|
2020
Q2 | $12.1M | Buy |
100,802
+2,742
| +3% | +$320K | 1.19% | 25 |
|
|
2020
Q1 | $10.8M | Sell |
98,060
-325
| -0.3% | -$39K | 1.31% | 22 |
|
|
2019
Q4 | $12.3M | Sell |
98,385
-818
| -0.8% | -$100K | 1.22% | 25 |
|
|
2019
Q3 | $12.3M | Sell |
99,203
-125
| -0.1% | -$14.8K | 1.34% | 23 |
|
|
2019
Q2 | $10.9M | Sell |
99,328
-50
| -0.1% | -$5.33K | 1.16% | 28 |
|
|
2019
Q1 | $10.3M | Buy |
99,378
+44
| +0% | +$4.28K | 1.13% | 28 |
|
|
2018
Q4 | $9.13M | Buy |
99,334
+1,237
| +1% | +$111K | 1.19% | 30 |
|
|
2018
Q3 | $8.16M | Sell |
98,097
-36
| -0% | -$2.94K | 0.92% | 33 |
|
|
2018
Q2 | $7.66M | Sell |
98,133
-1,916
| -2% | -$144K | 0.96% | 29 |
|
|
2018
Q1 | $7.93M | Sell |
100,049
-5,548
| -5% | -$463K | 1.03% | 30 |
|
|
2017
Q4 | $9.7M | Sell |
105,597
-1,456
| -1% | -$131K | 1.25% | 20 |
|
|
2017
Q3 | $9.74M | Buy |
107,053
+657
| +0.6% | +$59.8K | 1.3% | 20 |
|
|
2017
Q2 | $9.27M | Buy |
106,396
+2,441
| +2% | +$215K | 1.27% | 19 |
|
|
2017
Q1 | $9.34M | Sell |
103,955
-1,279
| -1% | -$113K | 1.29% | 18 |
|
|
2016
Q4 | $8.85M | Sell |
105,234
-3,059
| -3% | -$261K | 0.87% | 40 |
|
|
2016
Q3 | $9.72M | Sell |
108,293
-359
| -0.3% | -$31.2K | 0.8% | 44 |
|
|
2016
Q2 | $9.2M | Sell |
108,652
-9,500
| -8% | -$780K | 0.74% | 46 |
|
|
2016
Q1 | $9.72M | Sell |
118,152
-133
| -0.1% | -$10.7K | 0.7% | 48 |
|
|
2015
Q4 | $9.39M | Sell |
118,285
-410
| -0.3% | -$31.3K | 0.64% | 54 |
|
|
2015
Q3 | $8.54M | Sell |
118,695
-3,832
| -3% | -$287K | 0.55% | 55 |
|
|
2015
Q2 | $9.59M | Sell |
122,527
-2,023
| -2% | -$163K | 0.53% | 54 |
|
|
2015
Q1 | $10.2M | Sell |
124,550
-996
| -0.8% | -$85.6K | 0.54% | 52 |
|
|
2014
Q4 | $11.4M | Sell |
125,546
-653
| -0.5% | -$57.5K | 0.55% | 53 |
|
|
2014
Q3 | $10.6M | Sell |
126,199
-109
| -0.1% | -$8.93K | 0.51% | 57 |
|
|
2014
Q2 | $9.93M | Sell |
126,308
-91
| -0.1% | -$7.34K | 0.47% | 60 |
|
|
2014
Q1 | $10.2M | Sell |
126,399
-964
| -0.8% | -$76K | 0.49% | 57 |
|
|
2013
Q4 | $10.4M | Sell |
127,363
-304
| -0.2% | -$24.8K | 0.5% | 56 |
|
|
2013
Q3 | $9.65M | Buy |
127,667
+93
| +0.1% | +$7.4K | 0.5% | 59 |
|
|
2013
Q2 | $9.82M | Buy |
+127,574
| New | +$10M | 0.53% | 60 |
|
Other funds holding PG
Ashfield Capital Partners's PG Position: Q3 2022 in Review
Ashfield Capital Partners reduced its Procter & Gamble (PG) stake by 1.9% in Q3 2022, selling an estimated $240K and leaving 88,815 shares worth $11.2M. The position accounts for 0.94% of the portfolio, ranked #28.
Ashfield Capital Partners first reported a position in PG in Q2 2013 and has held it in 38 quarters since. The position peaked at $15M in Q4 2021. 3,195 funds tracked by Wall St. Rank hold PG as of Q3 2022.
- Ashfield Capital Partners held 88,815 shares of Procter & Gamble worth $11.2M as of Q3 2022.
- Ashfield Capital Partners sold 1,691 Procter & Gamble shares in Q3 2022, an estimated $240K.
- Procter & Gamble made up 0.94% of Ashfield Capital Partners's portfolio in Q3 2022, its #28 holding.
- Ashfield Capital Partners first reported a position in Procter & Gamble in Q2 2013 and has held it in 38 quarters since.
- Ashfield Capital Partners's Procter & Gamble position peaked at $15M in Q4 2021.
- 3,195 funds tracked by Wall St. Rank held Procter & Gamble as of Q3 2022.
Based on Ashfield Capital Partners's 13F filing for Q3 2022, filed 10 Nov 2022.